COSM
Price
$0.59
Change
-$0.03 (-4.84%)
Updated
Dec 20, 04:59 PM (EDT)
SHPMY
Price
$8.00
Change
-$0.75 (-8.57%)
Updated
Dec 18 closing price
Ad is loading...

COSM vs SHPMY

Header iconCOSM vs SHPMY Comparison
Open Charts COSM vs SHPMYBanner chart's image
Cosmos Health
Price$0.59
Change-$0.03 (-4.84%)
Volume$592
CapitalizationN/A
Shanghai Pharmaceuticals Holdings
Price$8.00
Change-$0.75 (-8.57%)
Volume$1.64K
CapitalizationN/A
COSM vs SHPMY Comparison Chart
Loading...
COSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COSM vs. SHPMY commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COSM is a Hold and SHPMY is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (COSM: $0.58 vs. SHPMY: $8.00)
Brand notoriety: COSM and SHPMY are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: COSM: 62% vs. SHPMY: 67%
Market capitalization -- COSM: $11.96M vs. SHPMY: $9.5B
COSM [@Medical Distributors] is valued at $11.96M. SHPMY’s [@Medical Distributors] market capitalization is $9.5B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $9.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COSM’s FA Score shows that 1 FA rating(s) are green whileSHPMY’s FA Score has 0 green FA rating(s).

  • COSM’s FA Score: 1 green, 4 red.
  • SHPMY’s FA Score: 0 green, 5 red.
According to our system of comparison, SHPMY is a better buy in the long-term than COSM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COSM’s TA Score shows that 4 TA indicator(s) are bullish while SHPMY’s TA Score has 4 bullish TA indicator(s).

  • COSM’s TA Score: 4 bullish, 6 bearish.
  • SHPMY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SHPMY is a better buy in the short-term than COSM.

Price Growth

COSM (@Medical Distributors) experienced а -19.27% price change this week, while SHPMY (@Medical Distributors) price change was -0.12% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +0.86%. For the same industry, the average monthly price growth was +2.51%, and the average quarterly price growth was +147.05%.

Reported Earning Dates

COSM is expected to report earnings on Apr 12, 2023.

Industries' Descriptions

@Medical Distributors (+0.86% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHPMY($9.5B) has a higher market cap than COSM($12M). SHPMY YTD gains are higher at: 16.659 vs. COSM (-58.660). SHPMY has higher annual earnings (EBITDA): 11.1B vs. COSM (-12.98M). SHPMY has higher revenues than COSM: SHPMY (241B) vs COSM (49.6M).
COSMSHPMYCOSM / SHPMY
Capitalization12M9.5B0%
EBITDA-12.98M11.1B-0%
Gain YTD-58.66016.659-352%
P/E RatioN/A8.39-
Revenue49.6M241B0%
Total Cash2.38MN/A-
Total Debt10.8MN/A-
FUNDAMENTALS RATINGS
COSM vs SHPMY: Fundamental Ratings
COSM
SHPMY
OUTLOOK RATING
1..100
7350
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
39
Fair valued
PROFIT vs RISK RATING
1..100
10079
SMR RATING
1..100
9881
PRICE GROWTH RATING
1..100
9043
P/E GROWTH RATING
1..100
636
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SHPMY's Valuation (39) in the null industry is somewhat better than the same rating for COSM (79). This means that SHPMY’s stock grew somewhat faster than COSM’s over the last 12 months.

SHPMY's Profit vs Risk Rating (79) in the null industry is in the same range as COSM (100). This means that SHPMY’s stock grew similarly to COSM’s over the last 12 months.

SHPMY's SMR Rating (81) in the null industry is in the same range as COSM (98). This means that SHPMY’s stock grew similarly to COSM’s over the last 12 months.

SHPMY's Price Growth Rating (43) in the null industry is somewhat better than the same rating for COSM (90). This means that SHPMY’s stock grew somewhat faster than COSM’s over the last 12 months.

COSM's P/E Growth Rating (6) in the null industry is in the same range as SHPMY (36). This means that COSM’s stock grew similarly to SHPMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COSMSHPMY
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
54%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
67%
Advances
ODDS (%)
Bullish Trend 26 days ago
88%
Bullish Trend 6 days ago
59%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 17 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
66%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
63%
View a ticker or compare two or three
Ad is loading...
COSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGC2.830.12
+4.43%
Canopy Growth Corp
GRWG1.660.05
+3.11%
GrowGeneration Corp
SITC15.460.45
+3.00%
SITE Centers Corp
XPO135.25-10.26
-7.05%
XPO
BGLC0.23-0.03
-12.80%
BioNexus Gene Lab Corp

COSM and

Correlation & Price change

A.I.dvisor tells us that COSM and YI have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that COSM and YI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COSM
1D Price
Change %
COSM100%
-5.82%
YI - COSM
21%
Poorly correlated
+16.96%
SUPN - COSM
20%
Poorly correlated
-0.95%
SNYR - COSM
18%
Poorly correlated
-12.11%
OGI - COSM
16%
Poorly correlated
+6.85%
INCR - COSM
14%
Poorly correlated
+11.19%
More

SHPMY and

Correlation & Price change

A.I.dvisor tells us that SHPMY and NSVGF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPMY and NSVGF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHPMY
1D Price
Change %
SHPMY100%
N/A
NSVGF - SHPMY
14%
Poorly correlated
N/A
COSM - SHPMY
12%
Poorly correlated
-5.82%
SHTDF - SHPMY
12%
Poorly correlated
-2.35%
ZYXI - SHPMY
7%
Poorly correlated
-1.79%
SHPMF - SHPMY
7%
Poorly correlated
N/A
More